---
document_datetime: 2025-11-06 14:50:33
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/temodal-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: temodal-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 5.3093508
conversion_datetime: 2025-12-26 20:35:12.791737
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Temodal

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproduct lifecycleprocedures,you mayneedtoalsorefertoEPAR-Proceduralsteps taken andscientific informationafterauthorisation(archive).

| Applicationnumber   | Scope                                  | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ²/ amendedon   | Product Information affected3   | Summary   |
|---------------------|----------------------------------------|-------------------------------------|------------------------------------------|---------------------------------|-----------|
| Article 61(3) /     | Notification acc.Article61(3)-Accepted | 06/11/2025                          |                                          | PL                              |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/N/0000309483                      | Update of the package leaflet with revised contactdetails of local representatives.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |            |     |
|---------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation type IA / EMA/VR/0000280114 | Thiswasanapplicationfor agroupof variations. B.III.1.bEuropeanPharmacopoeial TSE Certificate ofsuitabilityfor an active substance/startingmaterial/reagent/ intermediate/orexcipient-B.Il1.1.b.3 Updated certificate from an already approved manufacturer - Accepted B.III.1.bEuropeanPharmacopoeialTSE Certificate ofsuitabilityfor an active substance/startingmaterial/reagent/ intermediate/or excipient - B.III.1.b.3 Updatedcertificatefrom analready approved manufacturer- Accepted B.III.1.bEuropeanPharmacopoeial TSE Certificateofsuitabilityforanactive substance/startingmaterial/reagent/ intermediate/or excipient-B.Ill.1.b.4 Deletion of certificates(in casemultiple certificatesexistpermaterial)-Accepted | 04/07/2025 | N/A |
| Variation type IA / EMA/VR/0000278708 | B.I1.b.5 Change to in-process tests or limits applied during the manufacture of the finished product - B.I1.b.5.b Addition of a new test(s) and limits - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 11/06/2025 | N/A |

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000267522                | A.ADMINISTRATIVECHANGES-A.7 Deletion ofmanufacturingsitesfor an active substance,intermediate orfinishedproduct, packaging site, manufacturer responsible for batchrelease,sitewherebatchcontroltakes place, or supplier of a starting material, reagent or excipient (when mentioned in the dossier)*- Accepted   | 28/04/2025   | N/A   |    | Variation type IA /   |
|----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|----|-----------------------|
| Article 61(3) / EMA/N/0000264275 | -Notification acc.Article 61(3)-Accepted Updateofthepackageleafletwithrevised contactdetailsoflocalrepresentatives and deletion of 'United Kingdom (Northern Ireland)' from the list of local representatives in line with the QRD template v10.4.                                                                 | 22/04/2025   |       | PL |                       |